Paper41361972
Therapeutic Perspectives of SIRT6 Regulation: Computational Analysis of Activation and Inhibition by Bioactive Molecules.
de Carvalho Matias ÉG and 5 others. J Mol Recognit, 2026. Cited by 2 papers, by iCite.
Cite this record
ConductScience Library. Therapeutic Perspectives of SIRT6 Regulation: Computational Analysis of Activation and Inhibition by Bioactive Molecules. Papers, record 41361972. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41361972
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Therapeutic Perspectives of SIRT6 Regulation: Computational Analysis of Activation and Inhibition by Bioactive Molecules.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Sirtuins | Major topic |
| Humans | |
| Molecular Docking Simulation | |
| Ligands | |
| Catechin | |
| Quercetin | |
| Hydroxamic Acids | |
| Histone Deacetylase Inhibitors | |
| Protein Binding |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| Conselho Nacional de Desenvolvimento Científico e Tecnológico | PubMed | |||
| Coordenação de Aperfeiçoamento de Pessoal de Nível Superior | PubMed |
Source PubMed
References57
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 39550698 | Protein-Ligand Interaction Energies from Quantum-Chemical Fragmentation Methods: Upgrading the MFCC-Scheme with Many-Body Contributions. | J Phys Chem B | 2024 | https://conductscience.org/library/papers/39550698 | PubMed |
| 2 | 36918058 | Design, synthesis, and biological screening of a series of pyrazolo [1,5-a]quina-zoline derivatives as SIRT6 activators. | Eur J Pharm Sci | 2023 | https://conductscience.org/library/papers/36918058 | PubMed |
| 3 | 21362626 | Structure and biochemical functions of SIRT6. | J Biol Chem | 2011 | https://conductscience.org/library/papers/21362626 | PubMed |
| 4 | 38304231 | Investigation of protein-protein interactions and hotspot region on the NSP7-NSP8 binding site in NSP12 of SARS-CoV-2. | Front Mol Biosci | 2023 | https://conductscience.org/library/papers/38304231 | PubMed |
| 5 | 16955487 | Semiempirical GGA-type density functional constructed with a long-range dispersion correction. | J Comput Chem | 2006 | https://conductscience.org/library/papers/16955487 | PubMed |
| 6 | 10873683 | Phylogenetic classification of prokaryotic and eukaryotic Sir2-like proteins. | Biochem Biophys Res Commun | 2000 | https://conductscience.org/library/papers/10873683 | PubMed |
| 7 | 31880447 | Exploring the Binding Mechanism of GABAB Receptor Agonists and Antagonists through in Silico Simulations. | J Chem Inf Model | 2020 | https://conductscience.org/library/papers/31880447 | PubMed |
| 8 | 37171574 | A simple and consistent quantum-chemical fragmentation scheme for proteins that includes two-body contributions. | J Comput Chem | 2023 | https://conductscience.org/library/papers/37171574 | PubMed |
| 9 | 21241417 | Epicatechin gallate and catechin gallate are superior to epigallocatechin gallate in growth suppression and anti-inflammatory activities in pancreatic tumor cells. | Cancer Sci | 2011 | https://conductscience.org/library/papers/21241417 | PubMed |
| 10 | 24785705 | Discovery of novel and selective SIRT6 inhibitors. | J Med Chem | 2014 | https://conductscience.org/library/papers/24785705 | PubMed |
| 11 | 21378304 | Sirtuins at a glance. | J Cell Sci | 2011 | https://conductscience.org/library/papers/21378304 | PubMed |
| 12 | 26456828 | Identification of and Molecular Basis for SIRT6 Loss-of-Function Point Mutations in Cancer. | Cell Rep | 2015 | https://conductscience.org/library/papers/26456828 | PubMed |
| 13 | 26606496 | Improved Treatment of Ligands and Coupling Effects in Empirical Calculation and Rationalization of pKa Values. | J Chem Theory Comput | 2011 | https://conductscience.org/library/papers/26606496 | PubMed |
| 14 | 16439206 | Genomic instability and aging-like phenotype in the absence of mammalian SIRT6. | Cell | 2006 | https://conductscience.org/library/papers/16439206 | PubMed |
| 15 | 12666158 | Energies, structures, and electronic properties of molecules in solution with the C-PCM solvation model. | J Comput Chem | 2003 | https://conductscience.org/library/papers/12666158 | PubMed |
| 16 | 31844103 | Structural basis for the activation and inhibition of Sirtuin 6 by quercetin and its derivatives. | Sci Rep | 2019 | https://conductscience.org/library/papers/31844103 | PubMed |
| 17 | 39402950 | Quantum mechanical analysis of newly synthesized HIV-1 protease inhibitors: evaluation of wild-type and resistant strain binding interactions. | Phys Chem Chem Phys | 2024 | https://conductscience.org/library/papers/39402950 | PubMed |
| 18 | 38487000 | Discovery of a potent and highly selective inhibitor of SIRT6 against pancreatic cancer metastasis in vivo. | Acta Pharm Sin B | 2024 | https://conductscience.org/library/papers/38487000 | PubMed |
| 19 | 33470998 | In silico approach of modified melanoma peptides and their immunotherapeutic potential. | Phys Chem Chem Phys | 2021 | https://conductscience.org/library/papers/33470998 | PubMed |
| 20 | 16756498 | The biochemistry of sirtuins. | Annu Rev Biochem | 2006 | https://conductscience.org/library/papers/16756498 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 41361972 | Therapeutic Perspectives of SIRT6 Regulation: Computational Analysis of Activation and Inhibition by Bioactive Molecules. | J Mol Recognit | 2026 | https://conductscience.org/library/papers/41361972 |
Source PubMed
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| SIRT6 | 51548 | PubTator's text mining | https://conductscience.org/library/genes/51548 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41361972
GET https://conductscience.org/api/papers/v1/41361972/references?page=2